Experiences with clinical use of Pentapeptide
Zelenková, J.; Mazac, V.; Gregor, O.
Ceskoslovenska Gynekologie 27(5): 298-302
1973
ISSN/ISBN: 0374-6852 PMID: 4726989 Document Number: 68469
Document emailed within 1 workday
Related Documents
Torppa, M.Auri.; Kuikka, L.; Nevalainen, M.; Pitkälä, K.Hannele. 2016: Family physician experiences with and needs for clinical supervision: Associations between work experiences, professional issues and social support at work Patient Education and Counseling 99(7): 1198-1202Merchant, F.J.; Bombeck, C.T.; Pissidis, A.; Nyhus, L.M. 1972: Hepatic destruction of synthetic gastrin pentapeptide Journal of the National Medical Association 64(3): 246-249
Sidorova, N.I.; Semenov, T.E.; Surovaia, A.N.; Vengerov, I.I.; Strel'tsov, S.A. 1987: Interaction of synthetic pentapeptide with DNA: specificity of binding and compactness of DNA Molekuliarnaia Biologiia 21(6): 1534-1550
Slomczynska, U.; Leplawy, T.; Leplawy, M.T. 1991: An efficient chemical-enzymatic synthesis of LHRH N-terminal pentapeptide Biomedica Biochimica Acta 50(10-11): S205-S208
Fisenko, V.P.; Kasparov, S.A. 1991: The mediator spectrum of the action of morphine and the pentapeptide FK 33-824 on the neurons of the cerebral cortex Farmakologiia i Toksikologiia 54(2): 11-14
Nash, L.; Good, R.A.; Hatzfeld, A.; Goldstein, G.; Incefy, G.S. 1981: In vitro differentiation of two surface markers for immature T cells by the synthetic pentapeptide, thymopoietin Journal of Immunology 126(1): 150-153
Svendsen, L.B.; Guldager, N.; Christensen, L.; Christiansen, P.M. 1976: Effect of a pepsin-inhibitory pentapeptide upon the peptic activity and acidity of gastric secretion Scandinavian Journal of Gastroenterology 11(5): 459-464
Laerum, O.D.; Paukovits, W.R. 1984: Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo Experimental Hematology 12(1): 7-17
Whitehead, P.A.; Robinson, P.A.; Hume, W.J.; Keen, J.N. 1991: Identification and partial characterisation of a serum enzyme which hydrolyses epidermal inhibitory pentapeptide Biochemical and Biophysical Research Communications 175(3): 978-985
Niu, C.I.; Shi, Q.L.; Yang, S.Z.; Chen, Y.N.; Huang, T.J.; Lu, Z.X. 1986: Conformational studies on human proinsulin fragments: the pentapeptide derivative Bpoc-Gly-Pro-Gly-Ala-Gly-OH and its synthetic intermediates Biopolymers 25 Suppl: S157-S167
Lubbe, N.; Seitz, W.; Bornscheuer, A.; Verner, L. 1989: Erste klinische Erfahrungen mit dem S & W Kaloximet®, einem Gerät zur O2-Verbrauchsmessung in Anaesthesie und Intensivmedizin - Premières expériences cliniques du Kaloximet S et W* un appareil pour mesurer la consommation d'O2 en anesthésie et soins intensifs - First clinical experiences with the S & W Kaloximet, a device for oxygen consumption measurement der Anaesthesist (Berlin. Print) 38(3): 147-151
Simonsen, E.; Mellergård, M. 1986: The MCMI--Millon Clinical Multiaxial Inventory. Clinical experiences with a new questionnaire for assessing psychiatric patients Ugeskrift for Laeger 148(44): 2872-2875
Cremonini, V.; Ferri, P.; Artioli, G.; Sarli, L.; Piccioni, E.; Rubbi, I. 2015: Nursing students' experiences of and satisfaction with the clinical learning environment: the role of educational models in the simulation laboratory and in clinical practice Acta Bio-Medica: Atenei Parmensis 86(Suppl 3): 194-204
Salganik, R.I.; Argutinskaia, S.V.; Bersimbaev, R.I.; Zimonina, T.V. 1972: Disorders in the ability of gastric mucous membrane cells to induce histidine decarboxylase and secrete hydrochloric acid during prolonged aministration of gastrin pentapeptide Voprosy Meditsinskoi Khimii 18(4): 390-393
Svendsen, L.B.; Guldager, N.; Christiansen, P.M. 1975: Effect of a pepsin-inhibiting pentapeptide on the secretion of pepsin and hydrochloric acid in the stomach Ugeskrift for Laeger 137(39): 2267-2269
Kraska, T.; Zochowski, R.J.; Korewicki, J.; Opolski, G.; Pieniak, M. 1978: Preliminary clinical experiences with continuous intravenous nitroglycerin infusion in the treatment of acute myocardial infarct. Preliminary clinical communication Kardiologia Polska 21(4): 301-308
Salomon, G.; Elberling, C. 1971: E.R.A. clinical system and clinical experiences Nordisk Medicin 86(35): 1032
Daniels, A.J.; Matthews, J.E.; Viveros, O.H.; Leban, J.J.; Cory, M.; Heyer, D. 1995: Structure-activity relationship of novel pentapeptide neuropeptide y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding Molecular Pharmacology 48(3): 425-432
Kusakari, J.; Sato, Y.; Saijo, S.; Tomioka, S.; Kawamoto, K. 1978: Clinical experiences with pepleomycin (NK 631) Japanese Journal of Antibiotics 31(11): 659-663
Peter, K.; van Ackern, K.; Glocke, M.; Kraatz, J.; Lutz, H.; Martin, E. 1975: Clinical experiences with the hemodilution Klinische Anasthesiologie und Intensivtherapie 9: 10-16